Anlotinib may enhance the efficacy of anti-PD1 therapy by inhibiting the AKT pathway and promoting the apoptosis of CAFs in lung adenocarcinoma
Article in International Immunopharmacology (April 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Construction and efficacy test of a survival prediction model for locally advanced cervical cancer based on anti-angiogenesis
Article in European Journal of Obstetrics & Gynecology and Reproductive Biology (March 2024)
Transforming Growth Factor Beta 2 (TGFB2) mRNA Levels, in Conjunction with Interferon-Gamma Receptor Activation of Interferon Regulatory Factor 5 (IRF5) and Expression of CD276/B7-H3, Are Therapeutically Targetable Negative Prognostic Markers in Low-Grade Gliomas
Article in Cancers (March 2024)